Karyopharm Therapeutics Inc.
Public companyUpdated
- Headquarters
- NEWTON, Massachusetts
- Ticker
- KPTI
- CIK
- 0001503802
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
No executive changes on record.
Bankruptcy filings
1 on record
Filed Nov 2, 2026
Chapter 11
US Bankruptcy Court, Southern District of Texas
- 26-90827Docket
From federal court dockets in CourtListener's RECAP archive. We show that a case was filed, not how it ended. All bankruptcy filings
Related companies
Same industry, the same state first.
- ENANTA PHARMACEUTICALS INC
COO appointed: Tara L. Kieffer, Ph.D.
- VERTEX PHARMACEUTICALS INC / MA
member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
director appointed: Robert J. Spiegel, M.D.
- FILANA THERAPEUTICS, INC.
Class I director appointed: Jill M. Quigley
- CERENOME, INC.
Chief Business Officer appointed: Ronald A. Andrews
- GeoVax Labs, Inc.
director appointed: Shahin Behroyan
- Bankruptcy filing
Filed for Chapter 11
Karyopharm Therapeutics Inc. filed for Chapter 11 in the US Bankruptcy Court for the Southern District of Texas on Nov 2, 2026.
Court: Southern District of Texas
Case: 26-90827
Only one public record so far. We add events as soon as a new filing lands; watch Karyopharm Therapeutics Inc. to get them in your digest.
Last verified Nov 12, 2026